JACKSONVILLE, FLA - A revolutionary new heart treatment is offering new hope to patients considered ineligible for open heart surgery or at great risk of suffering serious surgical complications.
Known as Transcatheter Aortic Valve Replacement (TAVR), the minimally invasive procedure is now being used to treat patients suffering from severe aortic valve stenosis. One of the most common valve disease disorders, aortic stenosis typically results from aging, as calcium or scarring narrows and hardens the heart’s aortic valve. As blood flow through the valve becomes constricted, individuals may experience chest pain, shortness of breath, fainting and palpitations. For those with severe aortic stenosis, the condition can lead to congestive heart failure and even death.